UCB Pharm
- Health & Medical
UCB is a global biopharmaceutical company that focuses on developing innovative medicines and solutions to improve the lives of people with severe diseases of the immune system or central nervous system. The company was founded in Belgium in 1928, and since then, it has expanded its operations to more than 40 countries worldwide, including South Korea. UCB’s research and development efforts focus on creating new therapies for patients with conditions such as epilepsy, multiple sclerosis, Parkinson’s disease, and rheumatoid arthritis. They also work to improve existing treatments and therapies to make them more effective and accessible to patients.
Last updated: